Pro-inflammatory cytokine expression

Pro-inflammatory cytokine expression is the physiological process through which cells, particularly those of the innate and adaptive immune systems, synthesize and secrete signaling molecules such as TNF-alpha, IL-1, and IL-6 to initiate an inflammatory response (StatPearls, 2023). This process is primarily regulated at the transcriptional level by key intracellular signaling cascades, including the NF-kappaB, MAPK, and JAK/STAT pathways, which respond to pathogen-associated molecular patterns (PAMPs) or damage-associated molecular patterns (DAMPs) (PubMed, PMID: 28138233). While acute expression is vital for clearing infections and repairing tissue, dysregulated or chronic expression is a primary driver of pathology in autoimmune disorders, chronic inflammatory diseases, and cytokine release syndromes (NIH, 2022). Therapeutic strategies often aim to suppress this expression by inhibiting the upstream kinases or transcription factors that drive the gene transcription of these cytokines (Nature Reviews Drug Discovery, 2017). Consequently, "pro-inflammatory cytokine expression" serves as a critical phenotypic readout in drug discovery, although it represents a complex biological outcome rather than a single druggable molecular entity.

Other names

Cytokine productionInflammatory mediator expressionPro-inflammatory signalingCytokine synthesis

Modulation of gene transcription via inhibition of intracellular signaling pathways (e.g., JAK/STAT, NF-kappaB) or glucocorticoid receptor activation to downregulate the production of inflammatory mediators.